Cargando…
Prescription-Event Monitoring Study on Safety and Efficacy of Levonadifloxacin (Oral and I.V.) in Management of Bacterial Infections: Findings of Real-World Observational Study
BACKGROUND: Levonadifloxacin is a novel broad-spectrum antibiotic belonging to the benzoquinolizine subclass of quinolones. It is available in intravenous as well as oral formulation for the treatment of infections caused by common Gram-positive bacterial pathogens including methicillin-resistant St...
Autores principales: | Mehta, Yatin, Sutar, Anand R., Zirpe, Kapil, Kothari, Jay Narendra, Alapati, Chakravarthi, Pathak, Manu, Nagvekar, Vasant C., Mehta, Kapil Dev, Debnath, Khokan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848560/ https://www.ncbi.nlm.nih.gov/pubmed/35265478 http://dx.doi.org/10.4103/ijabmr.ijabmr_602_21 |
Ejemplares similares
-
Real-World Evidence of Efficacy and Safety of Levonadifloxacin (Oral and IV) in the Management of Acute Bacterial Skin and Skin Structure Infections (ABSSSI): Findings of a Retrospective, Multi-Center Study
por: Mehta, Kapil D, et al.
Publicado: (2022) -
Meeting the Unmet Need in the Management of MDR Gram-Positive Infections with Oral Bactericidal Agent Levonadifloxacin
por: Mehta, Yatin, et al.
Publicado: (2022) -
A Real-world Study on Prescription Pattern of Fosfomycin in Critical Care Patients
por: Zirpe, Kapil G, et al.
Publicado: (2021) -
Guidelines for Antibiotic Prescription in Intensive Care Unit
por: Khilnani,, GC, et al.
Publicado: (2019) -
Cytokine Storm in Novel Coronavirus Disease (COVID-19): Expert Management Considerations
por: Mehta, Yatin, et al.
Publicado: (2020)